Secondary care management of malignant hypertensionStatus:Awaiting developmentExpected publication date: TBC
Treprostinil diethanolamine for treating pulmonary arterial hypertension [TSID11772]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Aprocitentan for treating resistant hypertension [TSID10395]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC